FDA allows marketing of first medical device to prevent migraine headaches

Today, the U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain.
Source: Food and Drug Administration - Category: American Health Source Type: news